Latest Argent Biopharma (ASX:RGT) News
Page 1
Page 1 of 3
Argent BioPharma licences four cannabis genotypes worldwide in 15% profit deal
27 Oct 2026
Market Wrap - Week 43 (19 Oct -> 23 Oct) 2026
24 Oct 2026
Argent BioPharma reports A$11,000 cash as licensing strategy broadens
23 Oct 2026
Argent BioPharma adds NLC antivirals with sales-linked fees and potential equity
29 Sept 2026
Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026
29 Aug 2026
FDA Opens Regulatory Pathway for Argent BioPharma’s CannEpil Veterinary Program
26 Aug 2026
Healthcare Wrap - Week 32 (3 Aug -> 7 Aug) 2026
8 Aug 2026
Argent BioPharma Advances CannEpil® into US Veterinary Market with FDA Pathway
6 Aug 2026
Healthcare Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
Argent BioPharma Cuts US$5.5m Debt with Splash Licensing Deal, Advances Veterinary Assets
28 July 2026
Healthcare Wrap - Week 28 (6 July -> 10 July) 2026
11 July 2026